Newark, New Castle - 19702, USA, February 24, 2023 (GLOBE NEWSWIRE) -- According to the deep-dive market assessment study conducted by Growth Plus Reports, the world menorrhagia market was valued at THE US DOLLAR$ 19.23 billion in 2021 and is expected to post a revenue TACC of 5.5% reach $31.14 billion by 2030.
The global market for intrauterine devices has been analyzed from four different perspectives: therapeutics, route administration, distribution channel, and geography.
Request a sample copy of the research report: https://www.growthplusreports.com/inquiry/request-sample/menorrhalgia-market/8234
Excerpts from 'By Therapeutics Segmentation'
Hormonal agents and non-hormonal agents are the two therapeutic categories that make up the largest share of the global market for menorrhagia treatments. Non-hormonal therapies include anti-inflammatory drugs (NSAIDs) and antifibrinolytics. Hormonal agents include long-acting progestogens, ethinyl estradiol, and norethindrone. The market for menorrhagia treatments is anticipated to expand as a result of the increasing frequency of anemia and uterine fibroids. Menorrhagia affects 2 million American women, preventing some of them from working or exercising. The market for menorrhagia treatments is also growing as a result of additional factors such as affordable costs and easy access to treatment alternatives.
Extracts from 'By Route of Administration Segmentation'
The global menorrhagia market based on the route of administration is segmented into:
- Oral
- Vaginal
- transdermal
- Intrauterine
- Others
The most common form of oral medication is a pill or tablet. Examples include non-steroidal anti-inflammatory drugs and birth control pills (NSAIDs). A cream or gel-like substance called vaginal medication is placed in the vagina. A patch is often used to apply transdermal medications to the skin. A hormone-releasing intrauterine device is usually used to deliver intrauterine drugs into the uterus (IUD). Creams, gels, and ointments are the typical forms of topical treatments that are administered to the skin. Placed under the tongue, sublingual medications dissolve and enter the bloodstream.
Extracts from 'By Segmentation of the distribution channel'
The global menorrhagia market based on distribution channel is segmented into:
- online pharmacies
- Retail Pharmacies
- Hospital Pharmacies
These drugs, which come in both brand name and generic varieties, are frequently prescribed by OB/GYNs.
Excerpts from 'By Region Segmentation'
Geographically, the global menorrhagia market has been segmented into:
- North America
- Europe
- Pacific Asia
- Rest of the world
North America held a large share of the market in 2021, followed by Europe, due to the high incidence and prevalence of uterine cancer. An increase in the number of postmenopausal women and an increase in the country's obese population are noted to be other factors contributing to the high prevalence of uterine cancer in the US.
Approximately 50 to 60 percent of hysterectomies are performed when women experience hormonal imbalances, fibroids, or polyps, which cause excessive bleeding or menorrhagia. Many premenopausal women with menorrhagia seek options that will allow them to continue having children after surgical treatment. Finally, a vast majority of women are interested in less invasive procedures. Therefore, it is becoming apparent that more research and development is needed to meet the increasing demand for treatment options. Asia Pacific is likely to grow at a high CAGR during the forecast period. The accessibility of cost-effective diagnosis and treatment options for menorrhagia is a driver of market growth in the region. A further increase in healthcare spending and government findings are also expected to fuel the growth of the menorrhagia treatment market.
Excerpts from 'Competitive Landscape'
Certain competing competitors have an impact on the geographic growth, new debuts and approval of those products, as well as their advancement of already existing technologies. These market participants monitor their respective market shares to develop product strategies and collaborate with other companies to align with the criteria. As a result, the menorrhagia market is growing more rapidly. Some of the prominent competing companies in the global menorrhagia market include:
- Torrent Pharmaceuticals Ltd.
- Sun Pharmaceutical Industries Ltd
- Beximco Pharmaceuticals Ltd.
- Zydus Cadila
- Novartis AG
- Sunny Biosciences Inc.
- Mayne Pharma Group Limited
- Cipla Inc.
- Pfizer Inc.
- Bayer AG
Get your personalized report here: https://www.growthplusreports.com/inquiry/customization/menorrhalgia-market/8234
Menorrhalgia Market Scope
| report attribute | Details |
| Market size value in 2021 | $19.23 billion |
| Income forecast in 2030 | $31.14 billion |
| Growth rate | CAGR of 5.5% from 2022 to 2030 |
| Base year for estimate | 2021 |
| forecast period | 2022-2030 |
| historic year | 2020 |
| segments covered | Therapeutics, route of administration, distribution channel and region |
| regional scope | North America, Europe, Asia Pacific, and Rest of the World (ROW) |
Table of Contents
- INTRODUCTION
- market ecosystem
- Timeline under consideration
- Historic Years โ 2020
- Base Year โ 2021
- Planned years: 2022 to 2030
- Currency used in the report
- RESEARCH METHODOLOGY
- research focus
- Data Collection Methodology
- data sources
- secondary sources
- primary sources
- Market estimation approach
- Bottom up
- From top to bottom
- Market forecast model
- Limitations and assumptions
- PREMIUM PERSPECTIVES
- Current market trends (COVID-19 perspective)
- Key players and competitive positioning (2021)
- MARKET DYNAMICS
- drivers
- Constraints/Challenges
- Opportunities
- GLOBAL MENORRALGIA MARKET - ANALYSIS AND FORECAST, BY THERAPEUTIC
- hormonal agents
- nonhormonal agents
- GLOBAL MENORRALGIA MARKET - ANALYSIS AND FORECAST, BY ROUTE OF ADMINISTRATION
- Oral
- Vaginal
- transdermal
- Intrauterine
- Others
- GLOBAL MENORRALGIA MARKET - ANALYSIS AND FORECAST, BY DISTRIBUTION CHANNEL
- online pharmacies
- Retail Pharmacies
- Hospital Pharmacies
OCD Continuedโฆ
Download Free Sample Report Now @ https://www.growthplusreports.com/inquiry/request-sample/menorrhalgia-market/8234
VALUE PROPOSALS RELATED TO THE REPORT:
- Developed with complimentary analyst hours and expert interviews with every report
- Comprehensive quantitative and qualitative insights at the segment and sub-segment level
- Covid 19 impact trends and outlook
- Granular insights at global/regional/national level
- In-depth insights into market dynamics (drivers, restraints, opportunities) and the business environment
- General coverage of the competitive landscape
- win imperatives
- Comprehensive coverage on 'Strategic Developments' recorded by major market players
CUSTOMIZATION OPTIONS:
- Dealer Landscape Assessment
- price intelligence
- Customer base assessment
- Analysis of Investments and Initiatives
- 'Business Profile' of Key Players
Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction
Visit our report store at - https://www.growthplusreports.com/report-store
Explore related reports:
infection control market by product (sterilization, disinfection, endoscope reprocessing, protective barriers), end user (hospitals and clinics, pharmaceutical and medical device companies) โ Global Outlook and Forecast 2022-2030
Wound Care Film Market by product type (foam dressings, film dressings), application (chronic wounds, acute wounds), end user (hospitals, clinics) โ Global Outlook and Forecast 2022-2030
Invasive Fungal Infections Therapeutics Market By Drug Type (Polyenes, Echinocandins Triazoles), Disease Type (Invasive Aspergillosis, Coccidioidomycosis and Cedosporiosis, Invasive Candidemia and Candidiasis, Cryptococcal Meningitis) - Global Outlook and Forecasts 2022-2030
Aftermarket and Chromatography Consumables by product (columns and column accessories, autosamplers), technologies (liquid chromatography, gas chromatography), end user (pharmaceutical and biotechnology, academic and research institutes) - Global Outlook and Forecast 2020-2030
Respiratory Inhaler Market By product type (dry powder inhalers, metered dose inhalers, nebulizers) by patient type (adult, pediatric) and indication (asthma, COPD): global outlook and forecast 2020-2030
About us:
Growth Plus Reports is part of GRG Health, a global healthcare insight services company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
The Growth Plus portfolio of services builds on our core capabilities of secondary and primary research, market modeling and forecasting, benchmarking, analysis and strategy formulation to help clients create scalable and innovative solutions that set them up for growth. and future success.
We were awarded by the prestigious CEO Magazine as "The Most Innovative Healthcare Market Research Company in 2020.
/cloudfront-us-east-2.images.arcpublishing.com/reuters/ICSV74GOH5NSVAINGUXNAZR2UU.jpg?w=75&resize=75,75&ssl=1 "U.S. regulators warn banks to be on alert for crypto-related liquidity risks")
